IHS Chemical Week

People & Business :: People/Executives

AMRI appoints William Marth as board chairman

4:37 AM MDT | June 6, 2013 | Deepti Ramesh

Albany Molecular Research Inc. (AMRI; Albany, NY) says its board of directors has unanimously voted to separate the role of chairman and CEO and has named William Marth, an active member of the AMRI board, as chairman of the board, effective 5 June 2013. The position of chairman has been held by Thomas D'Ambra, since the company's founding. D'Ambra retains his roles as a member of the board, president, and CEO. Marth was appointed to the AMRI board in 2012.  Marth, formerly president and CEO of Teva – Americas, retired from Teva in 2012. He had...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa